AbbVie halts late-stage trial for lung cancer drug Rova-T

AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Authors: Pacheco JM, Camidge DR PMID: 30892100 [PubMed - as supplied by publisher]
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news
How much would you pay to bring a new MRI scanner to your hospital? Local hospital...Read more on AuntMinnie.comRelated Reading: Ontario ban on cremation after brachytherapy draws scrutiny Row erupts in Canada over radiologists' role in healthcare Canadian group tackles MRI waits through scheduling How IT innovation can improve healthcare in Canada Ottawa Hospital slashes lung cancer treatment time
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Publication date: Available online 20 March 2019Source: The Annals of Thoracic SurgeryAuthor(s): Till Plönes, Khaled Mardanzai, Dumitrita Gafencu, Jan Viehof, Thomas Hager, Dirk Theegarten, Ulrich Dührsen, Kaid Darwiche, Christian Taube, Clemens AignerAbstractBackgroundEndobronchial ultrasound-guided transbronchial needle aspirations (EBUS-TBNA) are well-established for staging lung cancer. A growing number of publications report on lymphoma diagnosis via EBUS-TBNA acquired cytology; however, current guidelines recommend histological diagnosis. Research on the value of EBUS-TBNA acquired cytology versus surgical ...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Authors: Bewersdorf JP, Stahl M, Zeidan AM Abstract INTRODUCTION: Immune system evasion is essential for tumor cell survival and is mediated by the immunosuppressive tumor microenvironment and the activation of inhibitory immune checkpoints. While immune checkpoint-based therapy yielded impressive results in several advanced solid malignancies such as melanoma and non-small cell lung cancer, its role in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) is still evolving. Areas covered: Here we review the immunology in the tumor microenvironment in the bone marrow and discuss the current preclinical an...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
(MedPage Today) -- News, features, and commentary about cancer-related issues
Source: MedPage Today Public Health - Category: American Health Source Type: news
A new Cambridge startup is hoping to develop an inexpensive, mobile tool to diagnose everything from the Zika virus to lung cancer.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Nano LettersDOI: 10.1021/acs.nanolett.8b04309
Source: Nano Letters - Category: Nanotechnology Authors: Source Type: research
(International Association for the Study of Lung Cancer) The Third Biennial IASLC-sponsored Small Cell Lung Cancer Workshop will be held at Memorial Sloan Kettering Cancer Center in New York City, April 3-5, 2019, and will focus on preclinical and clinical advances in small cell lung cancer (SCLC) research.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
In this study, we aimed to investigate whether lycopene cou...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Tags: Primary research Source Type: research
More News: Cancer | Cancer & Oncology | Health | Lung Cancer